Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19
Clinical trial NCT04338802 · UNKNOWN
Trial details
- NCT number
- NCT04338802
- Sponsor
- Huilan Zhang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-02
- Primary completion
- 2020-05-04
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.